Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1988 Jul;94(3):834–838. doi: 10.1111/j.1476-5381.1988.tb11594.x

alpha-Methyldopa produces mydriasis in the rat by stimulation of CNS alpha 2-adrenoceptors.

J A Hey 1, T Ito 1, M C Koss 1
PMCID: PMC1854015  PMID: 2902894

Abstract

1. The effects of i.v. administration of alpha-methyldopa (MD) on rat pupil diameter were investigated. All experiments were carried out in rats in which vagosympathetic nerve trunks were sectioned bilaterally at the cervical level. 2. In anaesthetized rats MD produced a marked dose-related increase in pupil diameter. The onset of pupillary response to MD was gradual and reached maximal levels 2-3 h after administration. 3. Pretreatment with alpha 2-adrenoceptor antagonists yohimbine (1.5 mg kg-1, i.v.) or idazoxan (0.5 mg kg-1, i.v.) blocked the pupillary response to MD. In contrast, the alpha 1-antagonists prazosin (1.0 mg kg-1, i.v.) and phenoxybenzamine (1.5 mg kg-1, i.v.) did not significantly alter the pupillary effects of MD. 4. Selective enzymatic blockade with 3-hydroxy-benzyl-hydrazine (NSD-1015; 25 mg kg-1, i.p.), a dopa-decarboxylase inhibitor, as well as bis (4-methyl-homopiperazinyl-thiocarbonyl) disulphide (FLA-63, 5.0 mg kg-1, i.p.), a dopamine-beta-hydroxylase inhibitor, prevented the mydriatic effect of MD. 5. The above findings support the hypothesis that MD produces a clonidine-like CNS mydriasis in the rat. This effect appears to be mediated primarily by the MD metabolite, alpha-methylnoradrenaline. 6. These results indicate that MD produces mydriasis in the rat by a CNS action. The mydriatic action of MD appears to be produced by its metabolite alpha-methylnoradrenaline which in turn stimulates CNS postsynaptic alpha 2-adrenoceptors.

Full text

PDF
834

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Berridge T. L., Gadie B., Roach A. G., Tulloch I. F. alpha 2-Adrenoceptor agonists induced mydriasis in the rat by an action within the central nervous system. Br J Pharmacol. 1983 Mar;78(3):507–515. doi: 10.1111/j.1476-5381.1983.tb08810.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. CARLSSON A., LINDQVIST M. In-vivo decarboxylation of alpha-methyl DOPA and alpha-methyl metatyrosine. Acta Physiol Scand. 1962 Jan;54:87–94. doi: 10.1111/j.1748-1716.1962.tb02331.x. [DOI] [PubMed] [Google Scholar]
  3. DAHLSTROEM A., FUXE K., HILLARP N. A., MALMFORS T. ADRENERGIC MECHANISMS IN THE PUPILLARY LIGHT-REFLEX PATH. Acta Physiol Scand. 1964 Sep-Oct;62:119–124. doi: 10.1111/j.1748-1716.1964.tb03959.x. [DOI] [PubMed] [Google Scholar]
  4. DAVIS R. A., DRAIN D. J., HORLINGTON M., LAZARE R., URBANSKA A. The effect of L-alpha-methyl DOPA and N-2-hydroxybenzyl-N-methyl hydrazine (NSD 1039) on the blood pressure of renal hypertensive rates. Life Sci. 1963 Mar;3:193–197. doi: 10.1016/0024-3205(63)90050-x. [DOI] [PubMed] [Google Scholar]
  5. Day M. D., Roach A. G., Whiting R. L. The mechanism of the antihypertensive action of -methyldopa in hypertensive rats. Eur J Pharmacol. 1973 Mar;21(3):271–280. doi: 10.1016/0014-2999(73)90126-x. [DOI] [PubMed] [Google Scholar]
  6. Gherezghiher T., Christensen H. D., Koss M. C. Studies on the mechanism of methyl-dopa-induced mydriasis in the cat. Naunyn Schmiedebergs Arch Pharmacol. 1982 Jul;320(1):58–62. doi: 10.1007/BF00499073. [DOI] [PubMed] [Google Scholar]
  7. Gherezghiher T., Koss M. C., Christensen H. D. Alpha-methyl-DOPA induced mydriasis in the cat. Relationship between pupillary response and the oculomotor perfusate concentration of methyldopa and its metabolites. Naunyn Schmiedebergs Arch Pharmacol. 1983 Nov;324(3):201–206. doi: 10.1007/BF00503895. [DOI] [PubMed] [Google Scholar]
  8. Gherezghiher T., Koss M. C. Clonidine mydriasis in the rat. Eur J Pharmacol. 1979 Aug 1;57(2-3):263–266. doi: 10.1016/0014-2999(79)90376-5. [DOI] [PubMed] [Google Scholar]
  9. Heise A., Kroneberg G. Central nervous alpha-adrenergic receptors and the mode of action of alpha-methyldopa. Naunyn Schmiedebergs Arch Pharmacol. 1973;279(3):285–300. doi: 10.1007/BF00500607. [DOI] [PubMed] [Google Scholar]
  10. Henning M., Rubenson A. Evidence that the hypotensive action of methyldopa is mediated by central actions of methylnoradrenaline. J Pharm Pharmacol. 1971 Jun;23(6):407–411. doi: 10.1111/j.2042-7158.1971.tb08671.x. [DOI] [PubMed] [Google Scholar]
  11. Henning M. Studies on the mode of action of alpha-methyldopa. Acta Physiol Scand Suppl. 1969;322:1–37. [PubMed] [Google Scholar]
  12. Hey J. A., Gherezghiher T., Koss M. C. Studies on the mechanism of clonidine-induced mydriasis in the rat. Naunyn Schmiedebergs Arch Pharmacol. 1985 Jan;328(3):258–263. doi: 10.1007/BF00515551. [DOI] [PubMed] [Google Scholar]
  13. Hoyer I., Van Zwieten P. A. The central hypotensive action of amphetamine, ephedrine, phentermine, chlorphentermine and fenfluramine. J Pharm Pharmacol. 1972 Jun;24(6):452–458. doi: 10.1111/j.2042-7158.1972.tb09031.x. [DOI] [PubMed] [Google Scholar]
  14. Ingenito A. J., Barrett J. P., Procita L. A centrally mediated peripheral hypotensive effect of alpha-methyldopa. J Pharmacol Exp Ther. 1970 Dec;175(3):593–599. [PubMed] [Google Scholar]
  15. Kobinger W., Pichler L. Differentiation of drugs acting centrally upon the cardiovascular system by means of sympathetic and vagal responses. Clin Exp Hypertens. 1978;1(2):229–249. doi: 10.3109/10641967809068606. [DOI] [PubMed] [Google Scholar]
  16. Koss M. C., Gherezghiher T., Nomura A. CNS adrenergic inhibition of parasympathetic oculomotor tone. J Auton Nerv Syst. 1984 Mar;10(1):55–68. doi: 10.1016/0165-1838(84)90067-5. [DOI] [PubMed] [Google Scholar]
  17. Koss M. C. Methyldopa produces central inhibition of parasympathetic activity in the cat. Naunyn Schmiedebergs Arch Pharmacol. 1980 Nov;314(2):135–139. doi: 10.1007/BF00504529. [DOI] [PubMed] [Google Scholar]
  18. Koss M. C. Pupillary dilation as an index of central nervous system alpha 2-adrenoceptor activation. J Pharmacol Methods. 1986 Feb;15(1):1–19. doi: 10.1016/0160-5402(86)90002-1. [DOI] [PubMed] [Google Scholar]
  19. Koss M. C., San L. C. Analysis of clonidine-induced mydriasis. Invest Ophthalmol. 1976 Jul;15(7):566–570. [PubMed] [Google Scholar]
  20. Torchiana M. L., Lotti V. J., Clark C. M., Stone C. A. Comparison of centrally mediated hypotensive action of methyldopa and DOPA in cats. Arch Int Pharmacodyn Ther. 1973 Sep;205(1):103–113. [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES